Fertility· July 19, 2026· 5 min read

PCOS Has a New Name: What Polyendocrine Metabolic Ovarian Syndrome (PMOS) Means for You

PCOS is now PMOS: polyendocrine metabolic ovarian syndrome. Learn what the 2026 name change means for your diagnosis, fertility treatment, and care.

If you’ve been diagnosed with polycystic ovary syndrome, you may have seen headlines this year announcing that the condition has a new name. It’s true, and it’s a change decades in the making.

On May 12, 2026, an international coalition announced that polycystic ovary syndrome (PCOS) is now called polyendocrine metabolic ovarian syndrome (PMOS). The consensus was published in The Lancet and announced by the Endocrine Society alongside more than 50 patient and professional organizations worldwide.

Here’s what changed, what didn’t, and what it means if you’re trying to conceive.

Why The Name Changed

The old name pointed to the wrong thing.

“Polycystic ovary syndrome” told patients and clinicians that the condition was fundamentally about cysts on the ovaries. Research published alongside the consensus found there is no increase in abnormal ovarian cysts in people with the condition. The fluid-filled structures visible on ultrasound are follicles, a normal part of ovarian anatomy, not pathological cysts.

Meanwhile, the name said nothing about the parts of the condition that often matter most: hormone fluctuations, insulin resistance, metabolic health, mental health, and skin.

Professor Helena Teede of Monash University, who led the renaming effort, put it plainly in the Endocrine Society’s announcement:

“For too long, the name reduced a complex, long-term hormonal or endocrine disorder to a misunderstanding about ‘cysts’ and a focus on ovaries. This contributed to missed diagnoses and inadequate treatment.”

Dr. Lubna Pal of Yale Medicine described the shift as moving from a “microscopic” view of the condition to a “telescopic” one.

What The New Name Actually Says

Each word in polyendocrine metabolic ovarian syndrome does work the old name didn’t:

Polyendocrine. Multiple hormone systems are involved, not just the ovaries.
Metabolic. Insulin resistance, elevated long-term risk of type 2 diabetes, and cholesterol abnormalities are core features, not side notes.
Ovarian. The ovaries are still part of the picture, including irregular ovulation and elevated androgens.
Syndrome. It remains a cluster of related features that presents differently from person to person.

The condition affects roughly 1 in 8 women, more than 170 million people worldwide.

How The Change Was Made

This wasn’t a marketing decision. According to the Endocrine Society, it was the largest initiative ever undertaken to rename a medical condition.

The process took 14 years and gathered more than 22,000 survey responses from patients, along with multiple international workshops involving patients and multidisciplinary health professionals. Fifty-six patient and professional organizations participated.

The effort was co-led by Professor Teede with Professor Terhi Piltonen of Oulu University in Finland (President of the AE-PCOS Society), Professor Anuja Dokras in the United States, and Rachel Morman, Chair of Verity (PCOS UK).

The agreed principles for the new name were patient benefit, scientific accuracy, ease of communication, avoidance of stigma, cultural appropriateness, and a real implementation plan. Piltonen noted that the team deliberately avoided reproductive terms that could increase stigma for women in some cultural contexts.

Morman, who brought lived experience to the process, said: “It is fantastic that the new name now leads with hormones and recognizes the metabolic dimension of the condition. This shift will reframe the conversation and demand that it is taken as seriously as the long-term, complex health condition it is.”

What Has N ot Changed

This is the most important part for anyone currently in care.

The condition itself is the same. Your body hasn’t changed. Your symptoms haven’t changed.

Diagnostic criteria have not changed. The consensus renames the condition; it does not revise how it is diagnosed.

Treatment has not changed. Ovulation induction medications, metabolic management, lifestyle interventions, IUI, and IVF all remain exactly as they were.

Your existing diagnosis is still valid. A PCOS diagnosis on your chart is a PMOS diagnosis. Nothing needs to be re-done.

The Transition Timeline

The change is rolling out over a three-year transition period supported by an international education and awareness campaign. During this window, you’ll see both names used, often together, as “PMOS (formerly PCOS).”

Key milestones:

May 2026. New name announced and published in The Lancet.
2026 to 2028. Transition period, with both names in use across clinical and research settings.
2028. The new name is to be fully implemented in the updated International Guideline.

So if your chart says PCOS, your lab requisition says PMOS, and your insurance paperwork says something else entirely, that’s expected for now. It’s the same condition.

What This Means If You’re Trying To Conceive

PMOS is one of the most common causes of infertility, because the hormonal imbalances involved can disrupt ovulation. Irregular or absent ovulation makes timing conception difficult, and it’s often the reason people first come to a fertility clinic.

But a PMOS diagnosis does not mean pregnancy is out of reach. Many people with PMOS conceive naturally. Others benefit from lifestyle interventions, medications that stimulate ovulation, or fertility treatments including IUI and IVF.

What the new name may improve is how completely you get evaluated. When a condition is framed as “ovarian cysts,” the metabolic picture is easy to overlook, and insulin resistance, weight, and cardiometabolic health all influence both fertility outcomes and long-term health. A name that leads with hormones and metabolism makes it harder for that part of your care to fall through the cracks.

Lorna Berry, an Australian woman with PMOS who participated in the renaming process, described the goal this way: “This is about accountability and progress. It is about my daughters, their daughters, and the countless women yet to be born. We deserve clarity, understanding, and equitable healthcare from the very beginning.”

Questions We’re Hearing

Do I need a new diagnosis? No. Your existing diagnosis carries over.

Will my insurance coverage change? The consensus renames the condition; it does not alter clinical criteria or treatment recommendations. Coding systems and payer language will update over the transition period.

Should I say PCOS or PMOS? Either is understood right now. Many clinicians and organizations are using “PMOS (formerly PCOS)” during the transition.

Does this mean new research or new treatments? Not directly. The renaming is intended to improve recognition, diagnosis, and research framing over time. The organizers describe it as a step toward better long-term care, not a treatment change.

Talk To Us

If you have PMOS and are trying to conceive, or you have symptoms like irregular cycles, excess hair growth, or acne and have never been evaluated, a fertility specialist can assess both the reproductive and metabolic sides of the condition.

Contact New Hope Fertility Institute to schedule a consultation.